95 related articles for article (PubMed ID: 2823188)
1. Identification of autoreactive lymphocytotoxic antibodies in sensitised dialysis and kidney transplant patients.
Barocci S; Nocera A; Carozzi S; Leprini A; Fontana I; Armani R; Valente U; Lamperi S; Celada F
Nephrol Dial Transplant; 1987; 2(4):266-70. PubMed ID: 2823188
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive lymphocytotoxic IgM antibodies in highly sensitized dialysis patients waiting for a kidney transplant: identification and clinical relevance.
Barocci S; Valente U; Gusmano R; Perfumo F; Cantarella S; Leprini A; Icardi A; Nocera A
Clin Nephrol; 1991 Jul; 36(1):12-20. PubMed ID: 1889147
[TBL] [Abstract][Full Text] [Related]
3. [Characterization with dithiothreitol (DTT) of IgM auto-lymphocytotoxic antibodies in dialyzed patients awaiting kidney transplants].
Barocci S; Nocera A; Mossa M; Mantero D; Leprini A; Valente U
Boll Soc Ital Biol Sper; 1989 Aug; 65(8):743-50. PubMed ID: 2803737
[TBL] [Abstract][Full Text] [Related]
4. [Significance of lymphocytotoxic antibodies in kidney transplantation revisited (author's transl)].
Gluckman JC; Foucault C; Patte R; Frantz P; Bedrossian J; Nebout T; Chapuis F; Klatzmann D; Gomez AM
Nouv Presse Med; 1981 Feb; 10(5):303-7. PubMed ID: 7015277
[TBL] [Abstract][Full Text] [Related]
5. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
Drannik GN; Driianskaia VE; Montag TS
Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
[TBL] [Abstract][Full Text] [Related]
6. CMV infection in patients with chronic renal failure and in those following transplantation.
Korcáková L; Kaslík J; Svobodová J; Kaslíková J; Bláha J; Sedlácková E; Franková V; Hásková V; Skibová J
Czech Med; 1988; 11(3):131-6. PubMed ID: 2852093
[TBL] [Abstract][Full Text] [Related]
7. Antiidiotypic activity in sera from sensitised potential transplant recipients.
al Muzairai IA; MacLeod AM; Innes A; Cunningham C; Stewart KN; Power DA; Catto GR
Nephrol Dial Transplant; 1988; 3(6):803-8. PubMed ID: 3147424
[TBL] [Abstract][Full Text] [Related]
8. [Cytomegalovirus infection and its effect on immunologic indicators in patients on a chronic dialysis regimen].
Korcáková L; Kaslík J; Svobodová J; Franková V; Hásková V; Kaslíková J; Bláha J
Vnitr Lek; 1988 Apr; 34(4):340-7. PubMed ID: 2839936
[No Abstract] [Full Text] [Related]
9. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
10. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.
Fietze E; Prösch S; Reinke P; Stein J; Döcke WD; Staffa G; Löning S; Devaux S; Emmrich F; von Baehr R
Transplantation; 1994 Sep; 58(6):675-80. PubMed ID: 7940686
[TBL] [Abstract][Full Text] [Related]
12. Absorption with K562 erythroblastoma cells as a means for discrimination between auto- and alloantibodies in sera of hypersensitized renal patients.
Baldy-Chudzik K; Nowakowska B; Kuśnierczyk P; Matej H
Arch Immunol Ther Exp (Warsz); 1994; 42(3):223-6. PubMed ID: 7487357
[TBL] [Abstract][Full Text] [Related]
13. Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection.
Nadasdy T; Smith J; Laszik Z; Waner JL; Johnson LD; Silva FG
Mod Pathol; 1994 Apr; 7(3):289-94. PubMed ID: 8058700
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
15. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
16. Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.
Fradet Y; Roy R; Lachance JG; Noël R
Clin Nephrol; 1982 Aug; 18(2):69-73. PubMed ID: 6754190
[TBL] [Abstract][Full Text] [Related]
17. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
[TBL] [Abstract][Full Text] [Related]
19. Serum antibody profile against herpesviruses in renal transplant recipients.
Carpi C; Donati M; Musiani M; Zerbini M; Cevenini R; Feletti C
Boll Ist Sieroter Milan; 1982; 61(3):245-7. PubMed ID: 6100358
[TBL] [Abstract][Full Text] [Related]
20. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
